PRESS RELEASE
News
-
-
PRESS RELEASE
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
Affluent Medical announces a capital increase without preferential subscription rights involving the trading of 6,190,831 shares. Edwards Lifesciences becomes a 9.21% shareholder after subscribing for €5 million. Risk factors are highlighted in the available prospectus -
-
-
-
-
-
-
PRESS RELEASE
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Affluent Medical achieves clinical objective of Dry pilot study in first two patients with Artus artificial urinary sphincter, marking successful activation and ease of implantation. Company progresses towards goal of study -
PRESS RELEASE
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter.
Affluent Medical successfully activates Artus artificial urinary sphincter in first two patients, addressing global incontinence need. Read more about the innovative medical device here
